1-5 of 5
James Jacobberger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Translating an HPFH-Mechanism into Oral Small Molecule Therapy for Beta-Hemoglobinopathies: Clinical Proof-of-Principle

Robert Molokie, Santosh L. Saraf, Lani Krauz, Michael Pacini, David Chan, Alana Aziz-Bradley, Rebeca Gansari, Taif Hassan, Philip Woost, James Jacobberger, Victor R. Gordeuk, Donald E. Lavelle, Joseph DeSimone, Yogenthiran Saunthararajah
Journal: Blood
Blood (2023) 142 (Supplement 1): 2524.
https://doi.org/10.1182/blood-2023-186228
Published: 2023
Journal Articles

A Phase II Study of Curcumin and Vitamin D in Previously Untreated Patients with Early Stage Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Basem M. William, MRCP, MD, Kaylee Brillhart, Manuel Afable, MD, Kristen Bakalarz, CNP, Brenda Cooper, MD, Hillard M Lazarus, MD, Stanton L. Gerson, MD, Richard Creger, PharmD, Kalyanam Nagabhushanam, PhD, James Grote, MD, Pingfu Fu, Sandeep Kunati, PhD, Shuming Yang, PhD, Yan Xu, PhD, Philip Woost, PhD, James Jacobberger, PhD, Marcos de Lima, MD, Paolo Caimi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1875.
https://doi.org/10.1182/blood-2018-99-112295
Published: 2018
Journal Articles

Pilot Use of a Novel DNA Methytransferase -1 (DNMT1) Flow Cytometric Pharmacodynamic Assay to Evaluate Response to Low-Dose Azacitidine Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Hematopoietic Cell Transplantation

Najla H El Jurdi, MD, Masumi Ueda, MD MA, BA, Philip Woost, PhD, Hillard M Lazarus, MD, Paolo Caimi, MD, Brenda W. Cooper, MD, Richard Creger, PhD, Jane A. Little, MD, Linda Baer, MSN, NP-C, AOCNP, Lauren Brister, MSN, NP-C, AOCNP, Ehsan Malek, MD, Leland Metheny, MD, Folashade Otegbeye, MBBChir, MPH, Ben K. Tomlinson, MD, Basem M. William, MRCP,MD, James Jacobberger, PhD, Marcos De Lima, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5503.
https://doi.org/10.1182/blood.V130.Suppl_1.5503.5503
Published: 2017
Journal Articles

A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib (MLN9708) for Relapsed/ Refractory Acute Myeloid Leukemia (AML)

Anjali S. Advani, MD, Brenda Cooper, MD, Paul Elson, PhD, Sudipto Mukherjee, MD, PhD, M.P.H., Jaime Fensterl, Aaron T. Gerds, MD MS, Paolo F. Caimi, MD, Ben K. Tomlinson, MD, Ehsan Malek, MD, Jane A. Little, MD, Mary Lynn Rush, Samjhana Bogati, BSN, Eric Parsons, Donna Kane, Hetty E. Carraway, MD MBA, Aziz Nazha, MD, Betty K. Hamilton, MD, Ronald Sobecks, MD, Barbara Bevier, Christopher Goebel, Cassie Zimmerman, MPH, Alek d Nielsen, B.S., Cassandra M. Hirsch, BSc, Jaroslaw P. Maciejewski, MD, PhD, FACP, Matt Kalaycio, MD, Marcos deLima, MD, James Jacobberger, Philip Woost, Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2016) 128 (22): 4065.
https://doi.org/10.1182/blood.V128.22.4065.4065
Published: 2016
Journal Articles

Normal bone marrow signal-transduction profiles: a requisite for enhanced detection of signaling dysregulations in AML

e-blood
James Marvin, Suchitra Swaminathan, Geoffrey Kraker, Amy Chadburn, James Jacobberger, Charles Goolsby
Journal: Blood
Blood (2011) 117 (15): e120–e130.
https://doi.org/10.1182/blood-2010-10-316026
Published: 2011